Brief: Gen Ilac Says It Signs Transition Agreement To Finish Distribution Relation With Biogen Inc
06/01/2025 05:23
Jan 6 (Reuters) - GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE
TİCARET GENIL.IS :
* SAID ON SATURDAY SIGNS A TRANSITION AGREEMENT TO FINISH
DISTRIBUTION RELATION WITH BIOGEN INC.
* DURING THIS TRANSITION PROCESS, GEN WILL CONTINUE TO SELL
THE
DRUGS WHICH PRODUCED BY BIOGEN INC. AND REGISTERED TO GEN UNTIL
TRANSFER OF MARKETTING AUTHORIZATIONS
* OFFICIAL TRANSACTIONS AND WORKS FOR TRANSFER OF MARKETTING
AUTHORIZATIONS WILL START SOON
Source text: urn:newsml:reuters.com:*:nIKA6pjvPj
Further company coverage: GENIL.IS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Gen Ilac ve Saglik Urunleri Sanayi Ticaret
See all newsBrief: Gen Ilac Says It Wins Pharmaceutical Tender In Kazakhstan, Expects $1.19 Million Sales Contribution In 2027
Brief: Gen Ilac Says It Participates In Kazakhstan Drug Procurement Tender Via Med Service Plus Authorized By Kazakhstan Representative Office Of Gen Ilac
Brief: Gen Ilac Says It Signs Supply And Distribution Agreement With Incyte On Oct 9
Brief: Gen Ilac Says It Completes Pharmaceutical Manufacturing Plant Investment In Azerbaijan
Brief: Gen Ilac Says It Is To Start Share Buyback Programme For Max 125 Mln Nominal Shares With Allocated Funds Of 1.5 Bln Lira